ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Lotus Eye Hospital and Institute Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹17.72 Cr (+35.94% YoY), net profit ₹43.95 lakh; H1 revenue ₹34.78 Cr (+30.96%), net profit ₹1.05 Cr (+59.44%).

Highlights
Revenue growthQ2 +35.94%, H1 +30.96% YoY
MarginsQ2 PBT margin ~3.2% (computed); H1 PBT +95.43%
Demand visibilityGrowing specialized ophthalmic demand cited; not quantified

Growth

H1 PBT ₹156.89 lakh, up 95.43%. H1 expenses ₹33.72 Cr, up 28.62%, below revenue growth.

Outlook

No numeric guidance. Qualitative plans: new hospitals and satellite centres, technology upgrades, phased expansion; capex not quantified.

Risks

No explicit headwinds disclosed. Cash only ₹1.74 Cr against ₹17.73 Cr borrowings; lease liabilities excluded from borrowings.

Source

Investor Presentation filed with BSE, NSE: LOTUSEYE. Summary written with AI assistance from the document.

Read the document ↗

Lotus Eye Hospital and Institute Ltd: key numbers

Share price
₹101.12
Market cap
₹210.3 Cr
Revenue (annual)
₹53.71 Cr
Net profit (annual)
₹0.08 Cr
P/E (TTM)
444.6×Sector 64.9×
Promoter holding
40.14%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Lotus Eye Hospital and Institute Ltd

All →